AFSANEH BARZI

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology LOS ANGELES, CA NPI 1265480412

General Payments — all program years on this page

$115,001.32

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 108
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $19,068.20 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $18,682.5011
Food and Beverage $303.704
Travel and Lodging $82.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $7,803.1421
2019 $4,971.289
2020 $19.681
2021 $28,842.0320
2022 $14,401.5513
2023 $39,895.4428
2024 $19,068.2016

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086138429 Bayer Healthcare Pharmaceuticals Inc. $700.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086169568 Bayer Healthcare Pharmaceuticals Inc. $700.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086194370 Bayer Healthcare Pharmaceuticals Inc. $700.00 04/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086210999 Bayer Healthcare Pharmaceuticals Inc. $3,500.00 06/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086212011 Bayer Healthcare Pharmaceuticals Inc. $1,050.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086233802 Bayer Healthcare Pharmaceuticals Inc. $2,100.00 03/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086245642 Bayer Healthcare Pharmaceuticals Inc. $1,400.00 01/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089397809 Daiichi Sankyo Inc. $1,935.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101735302 E.R. Squibb & Sons, L.L.C. $23.96 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104670917 AstraZeneca Pharmaceuticals LP $3,082.50 04/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105210450 AstraZeneca Pharmaceuticals LP $2,055.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105609955 AstraZeneca Pharmaceuticals LP $125.00 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120866490 BeiGene USA, Inc. $82.00 06/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1120866492 BeiGene USA, Inc. $140.76 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123538199 Dentsply Sirona Inc $13.98 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144953415 Takeda Pharmaceuticals U.S.A., Inc. $1,460.00 02/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.